Related references
Note: Only part of the references are listed.Structure of the nociceptin/orphanin FQ receptor in complex with a peptide mimetic
Aaron A. Thompson et al.
NATURE (2012)
Structural Insights from Binding Poses of CCR2 and CCR5 with Clinically Important Antagonists: A Combined In Silico Study
Gugan Kothandan et al.
PLOS ONE (2012)
Binding Site Analysis of CCR2 Through In Silico Methodologies: Docking, CoMFA, and CoMSIA
Gugan Kothandan et al.
CHEMICAL BIOLOGY & DRUG DESIGN (2011)
CSAR Benchmark Exercise of 2010: Combined Evaluation Across All Submitted Scoring Functions
Richard D. Smith et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2011)
Ligand Based CoMFA, CoMSIA and HQSAR Analysis of CCR5 Antagonists
Changdev G. Gadhe et al.
BULLETIN OF THE KOREAN CHEMICAL SOCIETY (2010)
Practical Considerations for Building GROMOS-Compatible Small-Molecule Topologies
Justin A. Lemkul et al.
JOURNAL OF CHEMICAL INFORMATION AND MODELING (2010)
Achieving reliability and high accuracy in automated protein docking: ClusPro, PIPER, SOU, and stability analysis in CAPRI rounds 13-19
Dima Kozakov et al.
PROTEINS-STRUCTURE FUNCTION AND BIOINFORMATICS (2010)
Discovery of Orally Active 3-Pyridinyl-tropane As a Potent Nociceptin Receptor Agonist for the Management of Cough
Shu-Wei Yang et al.
JOURNAL OF MEDICINAL CHEMISTRY (2009)
The anxiolytic-like effects of the novel, orally active nociceptin opioid receptor agonist 8-[bis(2-methylphenyl)methyl]-3-phenyl-8-azabicyclo[3.2.1]octan-3-ol (SCH 221510)
Geoffrey B. Varty et al.
JOURNAL OF PHARMACOLOGY AND EXPERIMENTAL THERAPEUTICS (2008)
The nociceptin/orphanin FQ receptor: a target with broad therapeutic potential
David G. Lambert
NATURE REVIEWS DRUG DISCOVERY (2008)
Nociceptin/orphanin FQ peptide receptors: Pharmacology and clinical implications
L. -C. Chiou et al.
CURRENT DRUG TARGETS (2007)
Setting up and running molecular dynamics simulations of membrane proteins
Christian Kandt et al.
METHODS (2007)
Daily intravesical instillation of 1 mg nociceptin/orphanin FQ for the control of neurogenic detrusor overactivity:: A multicenter, placebo controlled, randomized exploratory study
Massimo Lazzeri et al.
JOURNAL OF UROLOGY (2006)
GROMACS: Fast, flexible, and free
D Van der Spoel et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2005)
Recent advances towards the discovery of ORL-1 receptor agonists and antagonists
GC Bignan et al.
EXPERT OPINION ON THERAPEUTIC PATENTS (2005)
The nociceptin pharmacophore site for opioid receptor binding derived from the NMR structure and bioactivity relationships
MJ Orsini et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
A biomolecular force field based on the free enthalpy of hydration and solvation: The GROMOS force-field parameter sets 53A5 and 53A6
C Oostenbrink et al.
JOURNAL OF COMPUTATIONAL CHEMISTRY (2004)
Characterization of opiates, neuroleptics, and synthetic analogs at ORL1 and opioid receptors
N Zaveri et al.
EUROPEAN JOURNAL OF PHARMACOLOGY (2001)
Share Paper
